Geographic Access to Cancer Care and Breast Cancer Treatment in Low-Income Women
- PMID: 40730348
- DOI: 10.1097/MLR.0000000000002178
Geographic Access to Cancer Care and Breast Cancer Treatment in Low-Income Women
Abstract
Background: Little is known about the role of geographic access to oncologists in breast cancer treatment among low-income patients.
Methods: Using Missouri Cancer Registry-Medicaid claims data, we identified Medicaid enrollees aged 18-64 with newly diagnosed breast cancer from 2007 to 2015 (n=3930). Census tract-level geographic access to radiation oncologists (ROs), medical oncologists (MOs), and primary care physicians (PCPs) was quantified using the 2-step floating catchment area approach and categorized into tertiles. Logistic regression was used to estimate odds ratios (ORs) of undergoing mastectomy (vs. breast-conserving surgery), utilizing (yes/no), timely initiating (≤90 d post-surgery), and completing radiotherapy and chemotherapy, as well as being adherent to (medication possession ratio ≥80%) and continuing (<90-consecutive day gap) endocrine therapy (ET) in the first year.
Results: Compared with patients in census tracts with the greatest access to ROs, those in census tracts with the lowest access to ROs had higher odds of mastectomy (OR=1.23, 95% CI: 1.02-1.48, Ptrend =0.04), lower odds of radiotherapy completion (OR=0.68, 95% CI: 0.49-0.95, Ptrend =0.02), and similar odds of utilization and timely initiation of radiotherapy. Patients in census tracts with the lowest (vs. highest) access to MOs had comparable odds of utilization and timely initiation of chemotherapy but lower odds of chemotherapy completion (OR=0.71, 95% CI: 0.51-0.97, Ptrend =0.06). Geographic access to MOs and PCPs was unrelated to ET.
Conclusions: Geographic access to oncologists was associated with choice of surgery and completion of radiotherapy/chemotherapy for breast cancer among Medicaid enrollees, highlighting the importance of addressing geographic barriers to oncologists to improve their treatment adherence.
Keywords: breast cancer; health care access; low income; treatment.
Copyright © 2025 Wolters Kluwer Health, Inc. All rights reserved.
Conflict of interest statement
The authors declare no conflict of interest.
References
-
- Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. CA Cancer J Clin. 2024;74:12–49.
-
- American Cancer Society. Breast Cancer Facts & Figures 2022-2024. American Cancer Society, Inc; 2022.
-
- Yu XQ. Socioeconomic disparities in breast cancer survival: relation to stage at diagnosis, treatment and race. BMC Cancer. 2009;9:364.
-
- Le Blanc JM, Heller DR, Friedrich A, et al. Association of Medicaid expansion under the affordable care act with breast cancer stage at diagnosis. JAMA Surg. 2020;155:752–758.
-
- Chavez-MacGregor M, Lei X, Malinowski C, et al. Medicaid expansion, chemotherapy delays, and racial disparities among women with early-stage breast cancer. J Natl Cancer Inst. 2023;115:644–651.
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
